Literature DB >> 17355088

Alcoholic liver disease.

William W Yip1, Alastair D Burt.   

Abstract

Alcohol excess is associated with a spectrum of disease ranging from simple steatosis through steatohepatitis to cirrhosis and, in some, hepatocellular carcinoma. Alcoholic steatohepatitis itself has a variable histological picture, but a constant feature is the presence of ballooning degeneration of hepatocytes. Recent studies have emphasized the importance of apoptosis as a mechanism of cell death in this condition. It is accompanied by varying degrees of perivenular, centrilobular, and pericellular fibrosis. When severe and associated with perivenular liver cell necrosis (central sclerosing hyaline necrosis), there may be precirrhotic portal hypertension. The pattern of fibrosis may initially be diffuse with little nodule formation, but in time there is frequently the development of a micronodular cirrhosis. In approximately 15% of patients with established cirrhosis, hepatocellular carcinoma develops; several precursor lesions are now recognized which can be detected histologically. Several authors have drawn attention to additional components of the spectrum of alcoholic liver disease, including vascular changes, portal tract inflammation and fibrosis, ductular reaction, and iron overload. The morphology of alcoholic liver disease can be significantly affected by abstinence; furthermore, the clinical and morphological phenotype can be significantly influenced by the presence of comorbid conditions such as nonalcoholic fatty liver disease or viral hepatitis. Biopsy appearances can provide important prognostic information in alcoholic liver disease, and this review incorporates a proposed grading and staging schema for assessment of histological severity.

Entities:  

Mesh:

Year:  2006        PMID: 17355088     DOI: 10.1053/j.semdp.2006.11.002

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  37 in total

Review 1.  Histopathology of nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt; Dina G Tiniakos
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

2.  Interstrain differences in liver injury and one-carbon metabolism in alcohol-fed mice.

Authors:  Masato Tsuchiya; Cheng Ji; Oksana Kosyk; Svitlana Shymonyak; Stepan Melnyk; Hiroshi Kono; Volodymyr Tryndyak; Levan Muskhelishvili; Igor P Pogribny; Neil Kaplowitz; Ivan Rusyn
Journal:  Hepatology       Date:  2012-06-06       Impact factor: 17.425

3.  PTEN in liver diseases and cancer.

Authors:  Marion Peyrou; Lucie Bourgoin; Michelangelo Foti
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

4.  Is iron overload in alcohol-related cirrhosis mediated by hepcidin?

Authors:  Tariq Iqbal; Azzam Diab; Douglas G Ward; Matthew J Brookes; Chris Tselepis; Jim Murray; Elwyn Elias
Journal:  World J Gastroenterol       Date:  2009-12-14       Impact factor: 5.742

Review 5.  Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin?

Authors:  Henry Völzke
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

Review 6.  Alcoholic liver disease: pathogenesis and new targets for therapy.

Authors:  José Altamirano; Ramón Bataller
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-08-09       Impact factor: 46.802

Review 7.  The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?

Authors:  Luca Valenti; Anna Ludovica Fracanzani; Silvia Fargion
Journal:  Semin Immunopathol       Date:  2009-05-14       Impact factor: 9.623

Review 8.  Role of liver biopsy in nonalcoholic fatty liver disease.

Authors:  I L Ke Nalbantoglu; Elizabeth M Brunt
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

9.  Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans.

Authors:  Youngmi Jung; Kevin D Brown; Rafal P Witek; Alessia Omenetti; Liu Yang; Margon Vandongen; Richard J Milton; Ian N Hines; Richard A Rippe; Laurent Spahr; Laura Rubbia-Brandt; Anna Mae Diehl
Journal:  Gastroenterology       Date:  2008-02-14       Impact factor: 22.682

Review 10.  Current experimental perspectives on the clinical progression of alcoholic liver disease.

Authors:  Katja Breitkopf; Laura E Nagy; Juliane I Beier; Sebastian Mueller; Honglei Weng; Steven Dooley
Journal:  Alcohol Clin Exp Res       Date:  2009-07-23       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.